リファイン すべてリセット
距離:
ソート
雇用主/採用担当者
掲載日
所在地
職種
雇用主/採用担当者
すべてのフィルタ

Novelの求人-hamatatsu - 10 Job Positions Available

上位都市:
10 / 1 - 10 求人
Revolution Medicines 求人

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors

Revolution Medicines  28日前
Revolution Medicines 求人

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors

Revolution Medicines  27日前
Astellas Pharma 求人

General Information Job Advert Title: Senior Research Associate Location: Tsukuba, Ibaraki Division: Cell and Gene Therapy Research Employment Class: Permanent Description 【About Astellas】 Astellas is a global life sciences company committed to turning innovative science into

Astellas Pharma  22日前
BP 求人

Entity: Customers & Products Job Family Group: Research & Technology Group Job Description: Job Purpose The Expert Technologist Technology Deployment provides technical expertise to the Japan markets, help plan their future technology requirements, deploy new technology,

BP  10日前
Revolution Medicines 求人

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors

Revolution Medicines  8日前
Revolution Medicines 求人

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors

Revolution Medicines  8日前
Revolution Medicines 求人

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors

Revolution Medicines  8日前
Astellas Pharma 求人

General Information Job Advert Title: Scientist I, Bioanalytical Sciences Location: Tsukuba,Ibaraki Division: Early Development and Translational Science Employment Class: Permanent Description 【About Astellas】 Astellas is a global life sciences company committed to turning innovative science into

Astellas Pharma  6日前
Revolution Medicines 求人

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors

Revolution Medicines  14時間前
Astellas Pharma 求人

General Information Job Advert Title: Senior Scientist(Biology PJ lead) Location: Tsukuba,Ibaraki Division: Cell and Gene Therapy Research Employment Class: Permanent Description 【About Astellas】 Astellas is a global life sciences company committed to turning innovative science into

Astellas Pharma  1日前

新しい機会を逃さないで!

確認メールの送信先

メールを確認し、リンクをクリックして求人情報の受信を開始します。

最新の求人情報を受け取ることができます。

novel 求人 全国 hamatatsu

次も興味があるかもしれません:

RAS

Oncology

Japanese

Cancer

Advertisement

確認メールの送信先

メールを確認し、リンクをクリックして求人情報の受信を開始します。

すべてのフィルタ 申請する
ソート
雇用主/採用担当者